Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stool water content refers to the proportion of water within fecal matter, which is a critical determinant of stool consistency and transit time through the intestinal lumen (Rose et al., 2015). The intestinal lumen is the internal space of the gastrointestinal tract where digestion, nutrient absorption, and waste processing occur (Hall & Hall, 2020). While "stool water content and intestinal lumen" is not a specific molecular target such as a protein or receptor, it represents a key physiological endpoint for various pharmacological interventions aimed at treating gastrointestinal disorders (Schiller, 2001). Drugs such as osmotic laxatives (e.g., polyethylene glycol) increase stool water content by creating an osmotic gradient that draws fluid into the lumen, whereas secretagogues like linaclotide activate epithelial receptors to stimulate fluid secretion (Lembo et al., 2011). Conversely, antidiarrheal agents like loperamide slow intestinal motility, allowing more time for the intestinal mucosa to reabsorb water from the lumen, thereby decreasing stool water content (Schiller, 2017). Maintaining the balance of fluid within the intestinal lumen is essential for normal bowel function, and its dysregulation is central to the pathophysiology of constipation and diarrhea (Rose et al., 2015).
Pharmacological agents modulate stool water content by altering the osmotic pressure within the intestinal lumen, activating secretory pathways in the intestinal epithelium (e.g., GC-C or ClC-2 activation), or modifying gastrointestinal motility to influence the duration of water reabsorption.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stool water content and intestinal lumen.